These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26206991)

  • 1. [Characterisation of selected molecular mechanisms influencing pharmacokinetics and pharmacodynamics of antidepressants].
    Jeleń A; Sałagacka A; Balcerczak E
    Postepy Hig Med Dosw (Online); 2015 Jul; 69():753-62. PubMed ID: 26206991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do we need pharmacogenetics to personalize antidepressant therapy?
    Lanni C; Racchi M; Govoni S
    Cell Mol Life Sci; 2013 Sep; 70(18):3327-40. PubMed ID: 23272319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of genotyping cytochrome P450 enzymes in the treatment of depression.
    Dubovsky SL
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):369-79. PubMed ID: 25554071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics of antidepressant drugs.
    Horstmann S; Binder EB
    Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics-guided dose modifications of antidepressants.
    Seeringer A; Kirchheiner J
    Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study.
    Breitenstein B; Scheuer S; Pfister H; Uhr M; Lucae S; Holsboer F; Ising M; Brückl TM
    CNS Spectr; 2014 Apr; 19(2):165-75. PubMed ID: 23880209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic tests for controlling treatment with antidepressants].
    Bschor T; Baethge C; Hiemke C; Müller-Oerlinghausen B
    Nervenarzt; 2017 May; 88(5):495-499. PubMed ID: 28303314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression.
    Uhr M; Tontsch A; Namendorf C; Ripke S; Lucae S; Ising M; Dose T; Ebinger M; Rosenhagen M; Kohli M; Kloiber S; Salyakina D; Bettecken T; Specht M; Pütz B; Binder EB; Müller-Myhsok B; Holsboer F
    Neuron; 2008 Jan; 57(2):203-9. PubMed ID: 18215618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic considerations for current state-of-the-art antidepressants.
    Wyska E
    Expert Opin Drug Metab Toxicol; 2019 Oct; 15(10):831-847. PubMed ID: 31526279
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism.
    Porcelli S; Fabbri C; Spina E; Serretti A; De Ronchi D
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1101-15. PubMed ID: 21736534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharamacogenetics and antidepressant treatment in integrative psychiatry perspective.
    Mihaljević-Peles A; Sagud M; Bozina N; Zivković M
    Psychiatr Danub; 2008 Sep; 20(3):399-401. PubMed ID: 18827770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
    Bosch TM
    Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and personalized medicine in antidepressant treatment.
    Gvozdic K; Brandl EJ; Taylor DL; Müller DJ
    Curr Pharm Des; 2012; 18(36):5853-78. PubMed ID: 22681166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
    Kirchheiner J; Seeringer A
    Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy.
    Radosavljevic M; Svob Strac D; Jancic J; Samardzic J
    Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.
    Jaquenoud Sirot E; Knezevic B; Morena GP; Harenberg S; Oneda B; Crettol S; Ansermot N; Baumann P; Eap CB
    J Clin Psychopharmacol; 2009 Aug; 29(4):319-26. PubMed ID: 19593168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics and the pharmacological management of depression.
    Krauter RR; Cook SS
    Nurse Pract; 2011 Oct; 36(10):14-21; quiz 21-2. PubMed ID: 21937968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics in depression and antidepressants.
    Bondy B
    Dialogues Clin Neurosci; 2005; 7(3):223-30. PubMed ID: 16156381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.
    Quaranta S; Dupouey J; Colle R; Verstuyft C
    Therapie; 2017 Apr; 72(2):311-318. PubMed ID: 28237405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders.
    Kirchheiner J; Bertilsson L; Bruus H; Wolff A; Roots I; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S235-43. PubMed ID: 14677085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.